Cyllene Therapeutics’ experimental gene therapy EG110A has received US FDA [...]

NVision has deployed its POLARIS quantum-enhanced MRI platform at Hokkaido [...]

BioVie has reported topline results from a Phase 2 trial [...]

EpilepsyGTx has partnered with ClearPoint Neuro to support the targeted [...]

Theranica’s Nerivio wearable migraine therapy is now covered by health [...]

FDA has granted orphan drug designation to Tris Pharma’s investigational [...]

Neupulse, a UK-based neurotherapeutics company, has raised £3 million in [...]

Modulight Biotherapeutics has raised $12.2 million in a Seed funding [...]

MediciNova has been recognised with the Contract Research and Development [...]

Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]